These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 8998092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
    Gonzalez ER, Ornato JP, Lawson CL.
    Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL.
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.
    Innes GD, Vertesi L, Dillon EC, Metcalfe C.
    Ann Emerg Med; 1997 Jan; 29(1):126-34. PubMed ID: 8998091
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.
    Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, Siostrzonek P, Heinz G.
    Crit Care Med; 2001 Jun; 29(6):1149-53. PubMed ID: 11395591
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study.
    Ellenbogen KA, Dias VC, Plumb VJ, Heywood JT, Mirvis DM.
    J Am Coll Cardiol; 1991 Oct; 18(4):891-7. PubMed ID: 1894861
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.
    Ellenbogen KA, Dias VC, Cardello FP, Strauss WE, Simonton CA, Pollak SJ, Wood MA, Stambler BS.
    Am J Cardiol; 1995 Jan 01; 75(1):45-9. PubMed ID: 7801862
    [Abstract] [Full Text] [Related]

  • 14. Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone.
    Wattanasuwan N, Khan IA, Mehta NJ, Arora P, Singh N, Vasavada BC, Sacchi TJ.
    Chest; 2001 Feb 01; 119(2):502-6. PubMed ID: 11171729
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Frequency of "on-label" use of intravenous diltiazem for rate control in patients with acute-onset atrial fibrillation or atrial flutter.
    Gasbarro NM, DiDomenico RJ.
    Am J Health Syst Pharm; 2019 Feb 01; 76(4):214-220. PubMed ID: 30715182
    [Abstract] [Full Text] [Related]

  • 18. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
    Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN.
    J Am Coll Cardiol; 1999 Feb 01; 33(2):304-10. PubMed ID: 9973007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.